MEDOPHARM ADVANCED RESEARCH PRIVATE LIMITED
MEDOPHARM ADVANCED RESEARCH PRIVATE LIMITED is a TAMIL NADU based PRIVATE LIMITED company, Registered at dated 01-OCT-2024 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of MEDOPHARM ADVANCED RESEARCH PRIVATE LIMITED is U72100TN2024PTC173806 and registration number is 173806.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC CHENNAI India. Authorized share capital of MEDOPHARM ADVANCED RESEARCH PRIVATE LIMITED is Rs. 1000000 and its paid up capital is Rs. 1000000. It aspire to serve in NA activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
MEDOPHARM ADVANCED RESEARCH PRIVATE LIMITED has 2 directors PRAKASH CHORDIA, HASTIMAL CHORDIA,
The registered Email address of MEDOPHARM ADVANCED RESEARCH PRIVATE LIMITED is marpl24@rediffmail.com and its registered address is NO.50, KAYARAMBEDU VILLAGE GUDUVANCHERY CHENGALPATTU KANCHIPURAM TN 603202 IN TAMIL NADU TAMIL NADU india 603202.
The current status of MEDOPHARM ADVANCED RESEARCH PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
MEDOPHARM ADVANCED RESEARCH PRIVATE LIMITED
ROC CHENNAI
ACTIVE
U72100TN2024PTC173806
01-OCT-2024
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1000000
1000000
CONTACT DETAILS
603202
INDIA
NO.50, KAYARAMBEDU VILLAGE GUDUVANCHERY CHENGALPATTU KANCHIPURAM TN 603202 IN
marpl24@rediffmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
00976032 | PRAKASH CHORDIA | Director | 01/10/2024 |
07830974 | HASTIMAL CHORDIA | Director | 01/10/2024 |
Details Updated by Companies
Quick Links
- All Registered company of TAMIL NADU
- Company Registered in TAMIL NADU
- All Registered company of Kanchipuram in TAMIL NADU
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.